The company has received tentative approval from the US Food and Drug Administration (FDA) for its abbreviated new drug application (ANDA), Drospirenone Tablets in 4 mg strength, the Mumbai-based drug maker said in a statement.from Moneycontrol Business News https://ift.tt/e0pQY19
Comments
Post a Comment